Found: 12
Select item for more details and to access through your institution.
Multipotente Liganden mit kombinierter Cholinesterase- und Monoaminooxidase-Inhibition sowie Histamin-H<sub>3</sub>R-Antagonismus bei neurodegenerativen Erkrankungen.
- Published in:
- Angewandte Chemie, 2017, v. 129, n. 41, p. 12939, doi. 10.1002/ange.201706072
- By:
- Publication type:
- Article
Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H<sub>3</sub>R Antagonism for Neurodegenerative Diseases.
- Published in:
- Angewandte Chemie International Edition, 2017, v. 56, n. 41, p. 12765, doi. 10.1002/anie.201706072
- By:
- Publication type:
- Article
Acetylcholinesterase Inhibition of Diversely Functionalized Quinolinones for Alzheimer's Disease Therapy.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 11, p. 3913, doi. 10.3390/ijms21113913
- By:
- Publication type:
- Article
Automated Synthesis of New Quinoxalinetacrines.
- Published in:
- ChemistrySelect, 2020, v. 5, n. 21, p. 6491, doi. 10.1002/slct.202001593
- By:
- Publication type:
- Article
N -Hydroxy- N -Propargylamide Derivatives of Ferulic Acid: Inhibitors of Cholinesterases and Monoamine Oxidases.
- Published in:
- Molecules, 2022, v. 27, n. 21, p. 7437, doi. 10.3390/molecules27217437
- By:
- Publication type:
- Article
Predicting targets of compounds against neurological diseases using cheminformatic methodology.
- Published in:
- Journal of Computer-Aided Molecular Design, 2015, v. 29, n. 2, p. 183, doi. 10.1007/s10822-014-9816-1
- By:
- Publication type:
- Article
Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids.
- Published in:
- Drug Design, Development & Therapy, 2014, v. 8, p. 1893, doi. 10.2147/DDDT.S69258
- By:
- Publication type:
- Article
Synthesis of N -Substituted Pyrroles Catalyzed by Low-Cost and Commercially Available Aluminas.
- Published in:
- Catalysts (2073-4344), 2023, v. 13, n. 3, p. 603, doi. 10.3390/catal13030603
- By:
- Publication type:
- Article
Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent Developments.
- Published in:
- Chemical Record, 2021, v. 21, n. 1, p. 162, doi. 10.1002/tcr.202000107
- By:
- Publication type:
- Article
Triazolopyridopyrimidine: A New Scaffold for Dual-Target Small Molecules for Alzheimer's Disease Therapy.
- Published in:
- Molecules, 2020, v. 25, n. 14, p. 3190, doi. 10.3390/molecules25143190
- By:
- Publication type:
- Article
Synthesis and Biological Evaluation of Benzochromenopyrimidinones as Cholinesterase Inhibitors and Potent Antioxidant, Non-Hepatotoxic Agents for Alzheimer’s Disease.
- Published in:
- Molecules, 2016, v. 21, n. 5, p. 634, doi. 10.3390/molecules21050634
- By:
- Publication type:
- Article
Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinimines as Antioxidant, Cholinesterase, and Aβ<sub>1−42</sub> Aggregation Inhibitors for Alzheimer's Disease Therapy.
- Published in:
- ChemMedChem, 2016, v. 11, n. 12, p. 1318, doi. 10.1002/cmdc.201500539
- By:
- Publication type:
- Article